Progress on SOX9 and its enhancers in mammalian sex determination
Received date: 2024-05-23
Revised date: 2024-07-04
Online published: 2024-08-01
Supported by
Key R&D Program of Guangdong Province(2018B020203003)
The sex determination in mammals refers to the development of an initial bipotential organ, termed the bipotential gonad/genital ridge, into either a testis or an ovary at the early stages of embryonic development, under the precise regulation of transcription factors. SOX9 (SRY-box transcription factor 9) is a multifunctional transcription factor in mammalian development and plays a critical role in sex determination and subsequent male reproductive organs development. Recent studies have shown that several enhancers upstream of SOX9 also play an important role in the process of sex determination. In this review, we summarize the progress on the role of SOX9 and its gonadal enhancers in sex determination. This review will facilitate to understand the regulatory mechanism of sex determination of SOX9 and provides a theoretical basis for the further development of animal sex manipulation technologies.
Key words： mammals; sex determination; SOX9; non-coding region; enhancer
Min Yang, Siyuan Lin, Changqi Yang, Yaosheng Chen, Zuyong He . Progress on SOX9 and its enhancers in mammalian sex determination[J]. Hereditas(Beijing), 2024 , 46(9) : 677 -689 . DOI: 10.16288/j.yczz.24-146
| [1] | Sánchez L, Chaouiya C. Primary sex determination of placental mammals: a modelling study uncovers dynamical developmental constraints in the formation of sertoli and granulosa cells. BMC Syst Biol, 2016, 10(1): 37. |
| [2] | Bashamboo A, McElreavey K. Human sex-determination and disorders of sex-development (DSD). Semin Cell Dev Biol, 2015, 45: 77-83. |
| [3] | Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature, 1990, 346(6281): 240-244. |
| [4] | Vining B, Ming ZH, Bagheri-Fam S, Harley V. Diverse regulation but conserved function: SOX9 in vertebrate sex determination. Genes (Basel), 2021, 12(4): 486. |
| [5] | Kwok C, Goodfellow PN, Hawkins JR. Evidence to exclude SOX9 as a candidate gene for XY sex reversal without skeletal malformation. J Med Genet, 1996, 33(9): 800-801. |
| [6] | Meyer J, Südbeck P, Held M, Wagner T, Schmitz ML, Bricarelli FD, Eggermont E, Friedrich U, Haas OA, Kobelt A, Leroy JG, Van Maldergem L, Michel E, Mitulla B, Pfeiffer RA, Schinzel A, Schmidt H, Scherer G. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/ phenotype correlations. Hum Mol Genet, 1997, 6(1): 91-98. |
| [7] | Lavery R, Lardenois A, Ranc-Jianmotamedi F, Pauper E, Gregoire EP, Vigier C, Moreilhon C, Primig M, Chaboissier MC. XY Sox9 embryonic loss-of-function mouse mutants show complete sex reversal and produce partially fertile XY oocytes. Dev Biol, 2011, 354(1): 111-122. |
| [8] | Kim GJ, Sock E, Buchberger A, Just W, Denzer F, Hoepffner W, German J, Cole T, Mann J, Seguin JH, Zipf W, Costigan C, Schmiady H, Rostásy M, Kramer M, Kaltenbach S, R?sler B, Georg I, Troppmann E, Teichmann AC, Salfelder A, Widholz SA, Wieacker P, Hiort O, Camerino G, Radi O, Wegner M, Arnold HH, Scherer G. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development. J Med Genet, 2015, 52(4): 240-247. |
| [9] | Reyes AP, León NY, Frost ER, Harley VR. Genetic control of typical and atypical sex development. Nat Rev Urol, 2023, 20(7): 434-451. |
| [10] | Xie YS, Wu CH, Li ZC, Wu ZF, Hong LJ. Early gonadal development and sex determination in mammal. Int J Mol Sci, 2022, 23(14): 7500. |
| [11] | Svingen T, Koopman P. Building the mammalian testis: origins, differentiation, and assembly of the component cell populations. Genes Dev, 2013, 27(22): 2409-2426. |
| [12] | Orvis GD, Behringer RR. Cellular mechanisms of Müllerian duct formation in the mouse. Dev Biol, 2007, 306(2): 493-504. |
| [13] | Ostrer H. Sexual differentiation. Semin Reprod Med, 2000, 18(1): 41-49. |
| [14] | Albrecht KH, Eicheer EM. Evidence that Sry is expressed in pre-sertoli cells and sertoli and granulosa cells have a common precursor. Dev Biol, 2001, 240(1): 92-107. |
| [15] | Tevosian SG, Albrecht KH, Crispino JD, Fujiwara Y, Eicher EM, Orkin SH. Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development, 2002, 129(19): 4627-4634. |
| [16] | Bradford ST, Wilhelm D, Bandiera R, Vidal V, Schedl A, Koopman P. A cell-autonomous role for WT1 in regulating Sry in vivo. Hum Mol Genet, 2009, 18(18): 3429-3438. |
| [17] | Pilon N, Daneau I, Paradis V, Hamel F, Lussier JG, Viger RS, Silversides DW. Porcine SRY promoter is a target for steroidogenic factor 1. Biol Reprod, 2003, 68(4): 1098- 1106. |
| [18] | Fujimoto Y, Tanaka SS, Yamaguchi YL, Kobayashi H, Kuroki S, Tachibana M, Shinomura M, Kanai Y, Morohashi KI, Kawakami K, Nishinakamura R. Homeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development. Dev Cell, 2013, 26(4): 416-430. |
| [19] | Nef S, Verma-Kurvari S, Merenmies J, Vassalli JD, Efstratiadis A, Accili D, Parada LF. Testis determination requires insulin receptor family function in mice. Nature, 2003, 426(6964): 291-295. |
| [20] | Pitetti JL, Calvel P, Romero Y, Conne B, Truong V, Papaioannou MD, Schaad O, Docquier M, Herrera PL, Wilhelm D, Nef S. Insulin and IGF1 receptors are essential for XX and XY gonadal differentiation and adrenal development in mice. PLoS Genet, 2013, 9(1): e1003160. |
| [21] | Sekido R, Bar I, Narvaez V, Penny G, Lovell-Badge R. SOX9 is up-regulated by the transient expression of SRY specifically in sertoli cell precursors. Dev Biol, 2004, 274(2): 271-279. |
| [22] | Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature, 2008, 453(7197): 930-934. |
| [23] | Sekido R. SRY: a transcriptional activator of mammalian testis determination. Int J Biochem Cell Biol, 2010, 42(3): 417-420. |
| [24] | Bagheri-Fam S, Sim H, Bernard P, Jayakody I, Taketo MM, Scherer G, Harley VR. Loss of Fgfr2 leads to partial XY sex reversal. Dev Biol, 2008, 314(1): 71-83. |
| [25] | Hiramatsu R, Harikae K, Tsunekawa N, Kurohmaru M, Matsuo I, Kanai Y. FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. Development, 2010, 137(2): 303-312. |
| [26] | Moniot B, Declosmenil F, Barrionuevo F, Scherer G, Aritake K, Malki S, Marzi L, Cohen-Solal A, Georg I, Klattig J, Englert C, Kim Y, Capel B, Eguchi N, Urade Y, Boizet-Bonhoure B, Poulat F. The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in sertoli cells during male sexual differentiation. Development, 2009, 136(11): 1813-1821. |
| [27] | Rotgers E, J?rgensen A, Yao HHC. At the crossroads of fate-somatic cell lineage specification in the fetal gonad. Endocr Rev, 2018, 39(5): 739-759. |
| [28] | Sekido R, Lovell-Badge R. Sex determination and SRY: down to a wink and a nudge? Trends Genet, 2009, 25(1): 19-29. |
| [29] | Akiyama H, Lyons JP, Mori-Akiyama Y, Yang XH, Zhang R, Zhang ZP, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev, 2004, 18(9): 1072-1087. |
| [30] | Topol L, Chen W, Song H, Day TF, Yang YZ. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem, 2009, 284(5): 3323-3333. |
| [31] | Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combes AN, Beverdam A, Bowles J, Mizusaki H, Koopman P. Sertoli cell differentiation is induced both cell- autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol, 2005, 287(1): 111-124. |
| [32] | Georg I, Barrionuevo F, Wiech T, Scherer G. Sox9 and Sox8 are required for basal lamina integrity of testis cords and for suppression of FOXL2 during embryonic testis development in mice. Biol Reprod, 2012, 87(4): 99. |
| [33] | Chassot AA, Gillot I, Chaboissier MC. R-spondin1, WNT4, and the CTNNB1 signaling pathway: strict control over ovarian differentiation. Reproduction, 2014, 148(6): R97-R110. |
| [34] | Ohnesorg T, Vilain E, Sinclair AH. The genetics of disorders of sex development in humans. Sex Dev, 2014, 8(5): 262-272. |
| [35] | Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B. Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet, 2008, 17(19): 2949-2955. |
| [36] | Arboleda VA, Sandberg DE, Vilain E. DSDs: genetics, underlying pathologies and psychosexual differentiation. Nat Rev Endocrinol, 2014, 10(10): 603-615. |
| [37] | Pannetier M, Chassot AA, Chaboissier MC, Pailhoux E. Involvement of FOXL2 and RSPO1 in ovarian determination, development, and maintenance in mammals. Sex Dev, 2016, 10(4): 167-184. |
| [38] | Pannetier M, Fabre S, Batista F, Kocer A, Renault L, Jolivet G, Mandon-Pépin B, Cotinot C, Veitia R, Pailhoux E. FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol, 2006, 36(3): 399-413. |
| [39] | Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, Treier AC, Klugmann C, Klasen C, Holter NI, Riethmacher D, Schütz G, Cooney AJ, Lovell-Badge R, Treier M. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell, 2009, 139(6): 1130-1142. |
| [40] | Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Scherer G. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell, 1994, 79(6): 1111-1120. |
| [41] | Lecointre C, Pichon O, Hamel A, Heloury Y, Michel- Calemard L, Morel Y, David A, Familial acampomelic form of campomelic dysplasia caused by a 960 kb deletion upstream of SOX9. Am J Med Genet A, 2009, 149A(6): 1183-1189. |
| [42] | Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet, 2000, 16(4): 182-187. |
| [43] | Leung VYL, Gao B, Leung KKH, Melhado IG, Wynn SL, Au TYK, Dung NWF, Lau JYB, Mak ACY, Chan D, Cheah KSE. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet, 2011, 7(11): e1002356. |
| [44] | Symon A, Harley V. SOX9: a genomic view of tissue specific expression and action. Int J Biochem Cell Biol, 2017, 87: 18-22. |
| [45] | Kent J, Wheatley SC, Andrews JE, Sinclair AH, Koopman P. A male-specific role for SOX9 in vertebrate sex determination. Development, 1996, 122(9): 2813-2822. |
| [46] | Chaboissier MC, Kobayashi A, Vidal VIP, Lützkendorf S, van de Kant HJG, Wegner M, de Rooij DG, Behringer RR, Schedl A. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development, 2004, 131(9): 1891-1901. |
| [47] | Hacker A, Capel B, Goodfellow P, Lovell-Badge R. Expression of Sry, the mouse sex determining gene. Development, 1995, 121(6): 1603-1614. |
| [48] | Morais da Silva S, Hacker A, Harley V, Goodfellow P, Swain A, Lovell-Badge R. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet, 1996, 14(1): 62-68. |
| [49] | Bullejos M, Koopman P. Delayed Sry and Sox9 expression in developing mouse gonads underlies B6-Y(DOM) sex reversal. Dev Biol, 2005, 278(2): 473-481. |
| [50] | Wilhelm D, Washburn LL, Truong V, Fellous M, Eicher EM, Koopman P. Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice. Mech Dev, 2009, 126(5-6): 324-336. |
| [51] | Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet, 1995, 32(6): 415-420. |
| [52] | Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA, 2001, 98(12): 6698-6703. |
| [53] | Gonen N, Lovell-Badge R. The regulation of Sox9 expression in the gonad. Curr Top Dev Biol, 2019, 134: 223-252. |
| [54] | Vidal VP, Chaboissier MC, de Rooij DG, Schedl A. Sox9 induces testis development in XX transgenic mice. Nat Genet, 2001, 28(3): 216-217. |
| [55] | Lindeman RE, Gearhart MD, Minkina A, Krentz AD, Bardwell VJ, Zarkower D. Sexual cell-fate reprogramming in the ovary by DMRT1. Curr Biol, 2015, 25(6): 764-771. |
| [56] | Zhao L, Svingen T, Ng ET, Koopman P. Female-to-male sex reversal in mice caused by transgenic overexpression of Dmrt1. Development, 2015, 142(6): 1083-1088. |
| [57] | Rockich BE, Hrycaj SM, Shih HP, Nagy MS, Ferguson MAH, Kopp JL, Sander M, Wellik DM, Spence JR. Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. Proc Natl Acad Sci USA, 2013, 110(47): E4456-E4464. |
| [58] | Poché RA, Furuta Y, Chaboissier MC, Schedl A, Behringer RR. Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in muller glial cell development. J Comp Neurol, 2008, 510(3): 237-250. |
| [59] | Scott CE, Wynn SL, Sesay A, Cruz C, Cheung M, Gomez Gaviro MV, Booth S, Gao B, Cheah KSE, Lovell-Badge R, Briscoe J. SOX9 induces and maintains neural stem cells. Nat Neurosci, 2010, 13(10): 1181-1189. |
| [60] | Barrionuevo F, Bagheri-Fam S, Klattig J, Kist R, Taketo MM, Englert C, Scherer G. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol Reprod, 2006, 74(1): 195-201. |
| [61] | Vidal VPI, Chaboissier MC, Lützkendorf S, Cotsarelis G, Mill P, Hui CC, Ortonne N, Ortonne JP, Schedl A. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol, 2005, 15(15): 1340-1351. |
| [62] | Gordon CT, Tan TY, Benko S, Fitzpatrick D, Lyonnet S, Farlie PG. Long-range regulation at the SOX9 locus in development and disease. J Med Genet, 2009, 46(10): 649-656. |
| [63] | Cox JJ, Willatt L, Homfray T, Geoffrey Woods C. A SOX9 duplication and familial 46,XX developmental testicular disorder. N Engl J Med, 2011, 364(1): 91-93. |
| [64] | Vetro A, Ciccone R, Giorda R, Patricelli MG, Della Mina E, Forlino A, Zuffardi O. XX males SRY negative: a confirmed cause of infertility. J Med Genet, 2011, 48(10): 710-712. |
| [65] | Benko S, Gordon CT, Mallet D, Sreenivasan R, Thauvin-Robinet C, Brendehaug A, Thomas S, Bruland O, David M, Nicolino M, Labalme A, Sanlaville D, Callier P, Malan V, Huet F, Molven A, Dijoud F, Munnich A, Faivre L, Amiel J, Harley V, Houge G, Morel Y, Lyonnet S. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet, 2011, 48(12): 825-830. |
| [66] | Xiao B, Ji X, Xing Y, Chen YW, Tao J. A rare case of 46, XX SRY-negative male with approximately 74-kb duplication in a region upstream of SOX9. Eur J Med Genet, 2013, 56(12): 695-698. |
| [67] | Hyon C, Chantot-Bastaraud S, Harbuz R, Bhouri R, Perrot N, Peycelon M, Sibony M, Rojo S, Piguel X, Bilan F, Gilbert-Dussardier B, Kitzis A, McElreavey K, Siffroi JP, Bashamboo A. Refining the regulatory region upstream of SOX9 associated with 46,XX testicular disorders of sex development (DSD). Am J Med Genet A, 2015, 167A(8): 1851-1858. |
| [68] | Croft B, Ohnesorg T, Sinclair AH. The role of copy number variants in disorders of sex development. Sex Dev, 2018, 12(1-3): 19-29. |
| [69] | Ohnesorg T, van den Bergen JA, Belluoccio D, Shankara-Narayana N, Kean AM, Vasilaras A, Ewans L, Ayers KL, Sinclair AH. A duplication in a patient with 46,XX ovo-testicular disorder of sex development refines the SOX9 testis-specific regulatory region to 24 kb. Clin Genet, 2017, 92(3): 347-349. |
| [70] | Sajan SA, Brown CM, Davis-Keppen L, Burns K, Royer E, Coleman JAC, Hilton BA, DuPont BR, Perry DL, Taft RJ, Kesari A. The smallest likely pathogenic duplication of a SOX9 enhancer identified to date in a family with 46,XX testicular differences of sex development. Am J Med Genet A, 2023, 191(12): 2831-2836. |
| [71] | Schoenfelder S, Fraser P. Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet, 2019, 20(8): 437-455. |
| [72] | Benabdallah NS, Williamson I, Illingworth RS, Kane L, Boyle S, Sengupta D, Grimes GR, Therizols P, Bickmore WA. Decreased enhancer-promoter proximity accompanying enhancer activation. Mol Cell, 2019, 76(3): 473-484.e477. |
| [73] | Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, Sandstrom R, Bernstein B, Bender MA, Groudine M, Gnirke A, Stamatoyannopoulos J, Mirny LA, Lander ES, Dekker J. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science, 2009, 326(5950): 289-293. |
| [74] | Robson MI, Ringel AR, Mundlos S. Regulatory landscaping: how enhancer-promoter communication is sculpted in 3D. Mol Cell, 2019, 74(6): 1110-1122. |
| [75] | Misteli T. The self-organizing genome: principles of genome architecture and function. Cell, 2020, 183(1): 28-45. |
| [76] | Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature, 2012, 485(7398): 376-380. |
| [77] | Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, Piolot T, van Berkum NL, Meisig J, Sedat J, Gribnau J, Barillot E, Blüthgen N, Dekker J, Heard E. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature, 2012, 485(7398): 381-385. |
| [78] | Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J, Lee L, Lobanenkov VV, Ren B. A map of the cis-regulatory sequences in the mouse genome. Nature, 2012, 488(7409): 116-120. |
| [79] | Gonen N, Futtner CR, Wood S, Garcia-Moreno SA, Salamone IM, Samson SC, Sekido R, Poulat F, Maatouk DM, Lovell-Badge R. Sex reversal following deletion of a single distal enhancer of Sox9. Science, 2018, 360(6396): 1469-1473. |
| [80] | Croft B, Ohnesorg T, Hewitt J, Bowles J, Quinn A, Tan J, Corbin V, Pelosi E, van den Bergen J, Sreenivasan R, Knarston I, Robevska G, Vu DC, Hutson J, Harley V, Ayers K, Koopman P, Sinclair A. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nat Commun, 2018, 9(1): 5319. |
| [81] | Terao M, Ogawa Y, Takada S, Kajitani R, Okuno M, Mochimaru Y, Matsuoka K, Itoh T, Toyoda A, Kono T, Jogahara T, Mizushima S, Kuroiwa A. Turnover of mammal sex chromosomes in the Sry-deficient Amami spiny rat is due to male-specific upregulation of Sox9. Proc Natl Acad Sci USA, 2022, 119(49): e2211574119. |
| [82] | Ridnik M, Schoenfelder S, Gonen N. Cis-regulatory control of mammalian sex determination. Sex Dev, 2021, 15(5-6): 317-334. |
| [83] | Bernard P, Ryan J, Sim H, Czech DP, Sinclair AH, Koopman P, Harley VR. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer. Endocrinology, 2012, 153(2): 901-912. |
| [84] | Gonen N, Quinn A, O'Neill HC, Koopman P, Lovell-Badge R. Correction: Normal levels of Sox9 expression in the developing mouse testis depend on the TES/TESCO enhancer, but this does not act alone. PLoS Genet, 2017, 13(2): e1006584. |
| [85] | Ohnesorg T, Croft B, Tan J, Sinclair AH. Using ROADMAP data to identify enhancers associated with disorders of sex development. Sex Dev, 2016, 10(2): 59-65. |
| [86] | Ogawa Y, Terao M, Hara S, Tamano M, Okayasu H, Kato T, Takada S. Mapping of a responsible region for sex reversal upstream of Sox9 by production of mice with serial deletion in a genomic locus. Sci Rep, 2018, 8(1): 17514. |
| [87] | Ogawa Y, Terao M, Tsuji-Hosokawa A, Tsuchiya I, Hasegawa M, Takada S. SOX9 and SRY binding sites on mouse mXYSRa/Enh13 enhancer redundantly regulate Sox9 expression to varying degrees. Hum Mol Genet, 2023, 32(1): 55-64. |
| [88] | Ridnik M, Abberbock E, Alipov V, Lhermann SZ, Kaufman S, Lubman M, Poulat F, Gonen N. Two redundant transcription factor binding sites in a single enhancer are essential for mammalian sex determination. Nucleic Acids Res, 2024, 52(10): 5514-5528. |
| [89] | Zhao L, Wang CW, Lehman ML, He MY, An JY, Svingen T, Spiller CM, Ng ET, Nelson CC, Koopman P. Transcriptomic analysis of mRNA expression and alternative splicing during mouse sex determination. Mol Cell Endocrinol, 2018, 478: 84-96. |
| [90] | Georges A, L'H?te D, Todeschini AL, Auguste A, Legois B, Zider A, Veitia RA. The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells. Elife, 2014, 3: e04207. |
| [91] | Nicol B, Grimm SA, Gruzdev A, Scott GJ, Ray MK, Yao HHC. Genome-wide identification of FOXL2 binding and characterization of FOXL2 feminizing action in the fetal gonads. Hum Mol Genet, 2018, 27(24): 4273-4287. |
| [92] | Rossitto M, Déjardin S, Rands CM, Le Gras S, Migale R, Rafiee MR, Neirijnck Y, Pruvost A, Nguyen AL, Bossis G, Cammas F, Le Gallic L, Wilhelm D, Lovell-Badge R, Boizet-Bonhoure B, Nef S, Poulat F. TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway. Nat Commun, 2022, 13(1): 4412. |
| [93] | Bolt CC, Duboule D. The regulatory landscapes of developmental genes. Development, 2020, 147(3): dev171736. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号
